The firm has received conditional permission for Phases 1 and 2 human clinical trials. The subject expert committee has reviewed its proposal before giving the conditional nod.
HGCO19 Gennova Vaccine: India s first indigenous mRNA COVID-19 vaccine candidate gets nod for human trial financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
The region is associated with high aerosol loading, much of which is black carbon and dust, and thus provides an opportunity for studying how aerosol affects extreme rainfall events.
The mRNA vaccine candidate - HGCO19 - has been developed by Pune-based company Gennova.It is also supported with seed grant under the Ind-CEPI mission of the Department of Biotechnology under the Ministry of Science and Technology